PRL and colorectal cancer: We have previously demonstrated that MIA-602 and MIA-690, in addition to displaying antitumor activities, increase the expression of p53 in human PM cell lines [29], as well as in GH/prolactin-secreting pituitary adenoma cell lines [44] and colorectal cancer cells [23].